Author:
Mackert Michael,Guadagno Marie,Mabry Amanda,Chilek Lindsay
Abstract
Purpose
– The aim of this paper is to call for an increased focus on the ethics of direct-to-consumer (DTC) prescription drug advertising. This is important, not only to improve DTC prescription drug advertising, but also to inform DTC advertising of future medical advances.
Design/methodology/approach
– This conceptual paper discusses two examples of medical advances – personal genetic testing services and surgically implanted medical devices – to explain how investigating the research of DTC prescription drug advertising can set the stage for more ethical advertising of future medical advances.
Findings
– Specific issues related to health literacy, at-risk populations impacted by health disparities, and medicalization of issues common to aging relate to the DTC advertising of prescription drugs and other medical advances. Creative approaches to investigating these issues in the context of prescription drug advertising can enrich the debate about drug advertising, but also prepare researchers, policymakers, and consumers for future advertising of new medical developments.
Originality/value
– The value of this paper is its call for increased focus on the ethics of DTC prescription drug advertising, to improve the current marketing environment but also lay the foundation for other healthcare marketing in the future.
Reference71 articles.
1. Ad Hoc Committee on Health Literacy
(1999), “Health literacy: report of the council on scientific affairs”, Journal of the American Medical Association, Vol. 281 No. 6, pp. 552-557.
2. Auton, F.
(2004), “The advertising of pharmaceuticals direct to consumers: a critical review of the literature and debate”, International Journal of Advertising, Vol. 23 No. 1, pp. 5-52.
3. Ball, J.
and
Mackert, M.
(2013), “Pharmaceutical advertising practitioners' approach to trust and emotion”, International Journal of Pharmaceutical and Healthcare Marketing, Vol. 7 No. 3, pp. 244-264.
4. Bell, R.
,
Wilkes, M.
and
Kravitz, R.
(1999), “Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician that refuses”, Journal of Family Practice, Vol. 48 No. 6, pp. 446-452.
5. Black, S.A.
(2002), “Diabetes, diversity, and disparity: what do we do with the evidence?”, American Journal of Public Health, Vol. 92 No. 4, pp. 543-548.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Consumer Advertising and Health Communication;The Routledge Handbook of Health Communication;2021-08-26
2. Resisting stigma and evaluating realism in a direct-to-consumer advertisement for psychiatric drugs;International Journal of Pharmaceutical and Healthcare Marketing;2021-08-11
3. The Commercialization of Genetic Research: A Pilot Study;Acta Biomedica Scientifica;2021-06-24
4. Direct-to-Consumer Advertising;Social Aspects of Drug Discovery, Development and Commercialization;2016